Clinical Trial Update: Timing Optimization of Immunotherapy During Neoadjuvant Chemotherapy for Locally Advanced Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

This entry updates a Phase 2 clinical trial investigating the optimal timing of immunotherapy administered during neoadjuvant chemotherapy for locally advanced …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Snippet

Sponsor: Fujian Cancer Hospital | Conditions: Locally Advanced Nasopharyngeal Carcinoma | Phase 2 | Status: NOT_YET_RECRUITING